share_log

Moderna | DEFA14A: Others

Moderna | DEFA14A: Others

Moderna | DEFA14A:其他
SEC announcement ·  03/21 08:51
Moomoo AI 已提取核心訊息
Moderna, Inc. has filed a definitive proxy statement with the United States Securities and Exchange Commission (SEC). This filing is in accordance with Section 14(a) of the Securities Exchange Act of 1934, indicating that Moderna is preparing for upcoming corporate actions that require shareholder approval. The definitive proxy statement is a key document that outlines the agenda for the company's shareholder meeting, including matters such as election of directors, approval of compensation plans, and other significant corporate decisions. The document confirms that no filing fee is required for this submission.
Moderna, Inc. has filed a definitive proxy statement with the United States Securities and Exchange Commission (SEC). This filing is in accordance with Section 14(a) of the Securities Exchange Act of 1934, indicating that Moderna is preparing for upcoming corporate actions that require shareholder approval. The definitive proxy statement is a key document that outlines the agenda for the company's shareholder meeting, including matters such as election of directors, approval of compensation plans, and other significant corporate decisions. The document confirms that no filing fee is required for this submission.
Moderna, Inc. 已向美國證券交易委員會(SEC)提交了最終委託書。該文件符合1934年《證券交易法》第14(a)條,表明Moderna正在爲即將到來的需要股東批准的公司行動做準備。最終委託書是一份重要文件,概述了公司股東大會的議程,包括董事選舉、薪酬計劃的批准和其他重大公司決策等事項。該文件確認本次提交不需要任何申請費。
Moderna, Inc. 已向美國證券交易委員會(SEC)提交了最終委託書。該文件符合1934年《證券交易法》第14(a)條,表明Moderna正在爲即將到來的需要股東批准的公司行動做準備。最終委託書是一份重要文件,概述了公司股東大會的議程,包括董事選舉、薪酬計劃的批准和其他重大公司決策等事項。該文件確認本次提交不需要任何申請費。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息